MarkTScarboroughMD

Clinical Trials

• HLA Sensitization Following Major Cortical Allograft Bone Procedures Start of enrollment: 1999 Sep 01

  Completed

• Physical Characteristics of Retrieved Massive Allografts Start of enrollment: 1999 Dec 01

  Completed

• Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer Start of enrollment: 2005 Jan 01

  Completed

  Phase 2

• Clinical Orthopaedic Data Bank (Acute and Chronic) Start of enrollment: 2007 Jan 01

  Recruiting

• Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2007 Nov 01

  Completed

  Phase 3

• Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15

  Completed

  Phase 3

• Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Start of enrollment: 2009 Sep 01

  Recruiting

  Phase 3

• A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer Start of enrollment: 2012 Jan 01

  Completed

  Not Applicable

• Breast Cancer WEight Loss Study (BWEL Study) Start of enrollment: 2016 Aug 01

  Active, not recruiting

  Phase 3

• Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma Start of enrollment: 2016 Jul 01

  Completed

• Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS Start of enrollment: 2017 Feb 22

  Active, not recruiting

  Not Applicable

• CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy Start of enrollment: 2020 Mar 13

  Recruiting

  Phase 2

• Join now to see all